Trials / Completed
CompletedNCT02569879
Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 0 Days – 12 Months
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to assess impact of maternal immunisation against pertussis in infants ≤12 months of age before and after introduction of pertussis maternal immunisation in Bogota, Colombia from January 2005-December 2014.
Detailed description
An observational, retrospective, ecological database study which involves systematic screening of the national databases of Bogota, to study pertussis related morbidity and mortality in infants ≤ 12 months of age before and after introduction of pertussis maternal immunisation in Bogota, Colombia from January 2005-December 2014.
Conditions
- Diphtheria
- Acellular Pertussis
- Tetanus
- Aspergillosis, Allergic Bronchopulmonary
- Diphtheria-Tetanus-acellular Pertussis Vaccines
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pertussis maternal immunization | Retrospective time trend analysis before and after pertussis maternal immunization in Bogota, Colombia. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2018-04-14
- Completion
- 2018-04-14
- First posted
- 2015-10-07
- Last updated
- 2024-02-22
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT02569879. Inclusion in this directory is not an endorsement.